Skip to main content
Top

Angiogenesis

Issue 2/2012

Content (13 Articles)

Open Access Original Paper

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael P. Rosconi, Ergang Shi, Erica A. Pyles, George D. Yancopoulos, Neil Stahl, Stanley J. Wiegand

Original Paper

c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1

Francesca Anselmi, Maurizio Orlandini, Marina Rocchigiani, Caterina De Clemente, Ahmad Salameh, Claudia Lentucci, Salvatore Oliviero, Federico Galvagni

Original Paper

Angiogenic properties of myofibroblasts isolated from normal human skin wounds

Dominique Mayrand, Audrey Laforce-Lavoie, Sébastien Larochelle, Amélie Langlois, Hervé Genest, Michel Roy, Véronique J. Moulin

Original Paper

Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9

Jing Xu, Danhong Zhu, Shozo Sonoda, Shikun He, Christine Spee, Stephen J. Ryan, David R. Hinton

Original Paper

Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction

Yoon-Jin Lee, Hae-Jun Lee, Seo-hyun Choi, Yeung Bae Jin, Ho Jung An, Jin-Hyoung Kang, Sam S. Yoon, Yun-Sil Lee

Original Paper

Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions

Dilu Feng, Sabrina Welker, Christina Körbel, Jeannette Rudzitis-Auth, Michael D. Menger, Mathias Montenarh, Matthias W. Laschke

Original Paper

Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials

Rameshwar R. Rao, Alexis W. Peterson, Jacob Ceccarelli, Andrew J. Putnam, Jan P. Stegemann

Original Paper

VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients

Jon E. Peterson, David Zurakowski, Joseph E. Italiano Jr, Lea V. Michel, Susan Connors, Marsha Oenick, Robert J. D’Amato, Giannoula L. Klement, Judah Folkman

Open Access Original Paper

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

Giacomo Allegrini, Teresa Di Desidero, Maria Teresa Barletta, Anna Fioravanti, Paola Orlandi, Bastianina Canu, Silvio Chericoni, Fotios Loupakis, Antonello Di Paolo, Gianluca Masi, Andrea Fontana, Sara Lucchesi, Giada Arrighi, Mario Giusiani, Andrea Ciarlo, Giovanni Brandi, Romano Danesi, Robert S. Kerbel, Alfredo Falcone, Guido Bocci

Open Access Original Paper

Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation

Hyeong-Il Kwak, Hojin Kang, Jui M. Dave, E. Adriana Mendoza, Shih-Chi Su, Steve A. Maxwell, Kayla J. Bayless

Open Access Original Paper

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors

Maddalena Arigoni, Giuseppina Barutello, Stefania Lanzardo, Dario Longo, Silvio Aime, Claudia Curcio, Manuela Iezzi, Yujuan Zheng, Irmeli Barkefors, Lars Holmgren, Federica Cavallo

Original Paper

DNA methylation regulates lineage-specifying genes in primary lymphatic and blood endothelial cells

Simone Brönneke, Bodo Brückner, Nils Peters, Thomas C. G. Bosch, Franz Stäb, Horst Wenck, Sabine Hagemann, Marc Winnefeld

Erratum

Erratum to: MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway

Kathleen C. Brown, Jamie K. Lau, Aaron M. Dom, Theodore R. Witte, Haitao Luo, Clayton M. Crabtree, Yashoni H. Shah, Brandon S. Shiflett, Aileen J. Marcelo, Nancy A. Proper, W. Elaine Hardman, Richard D. Egleton, Yi Charlie Chen, Elsa I. Mangiarua, Piyali Dasgupta

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine